Binaural frequency difference limens in noise were obtained under homophasic and antiphasic conditions. Signal frequencies of 200, 300, 500, 700, and 1000 Hz were investigated at 5-and 10-dB sensation levels while 500 Hz was also explored at 15, 20, and 25 dB. The masker was a bandlimited noise with a spectrum level of 55 dB. Results indicate significant changes in discrimination behavior as a function of phase condition and sensation level. Alternative interpretations of the data are considered.
Frequency difference limens (DL's) were determined for three observers employing a 300 Hz target signal for NOSO, NOSπ, and NmSm at three sensations levels (SL's) above masked threshold (5, 10, and 15 dB) and two masker levels (20- and 59-dB spectrum level). The size of the frequency difference limen in noise is dependent upon the sensation level at which it is measured, the interaural phase of the target signal and the level of the noise. The difference limen is significantly larger when measured at low sensation levels under high-level noise when the target signal is 180° out of phase. This effect diminishes at higher sensation levels or when noise level is reduced, and does not appear when the signal is in phase or when a monaural noise-signal configuration is used. Masker level has no effect on the size of the DL for NOSO or NmSm but a differential effect was seen for NOSπ at 5 and 10 dB SL under the higher masker level where larger DL's were observed as compared to the lower masker level. Theses results are predictable from previous findings in regard to the band width employed by the auditory system under conditions where masking level differences (MLD's) are observed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.